Sun Cheng, Feng Shi-Bin, Cao Zheng-Wang, Bei Jun-Jie, Chen Qiang, Zhao Wei-Bo, Xu Xian-Jie, Zhou Zhou, Yu Zheng-Ping, Hu Hou-Yuan
Department of Cardiology, Southwest Hospital, Third Military Medical University, Chongqing, China.
Department of Occupational Health, Third Military Medical University, Chongqing, China.
Cell Physiol Biochem. 2017;41(6):2319-2332. doi: 10.1159/000475651. Epub 2017 Apr 27.
BACKGROUND/AIMS: Platelet microvesicles (PMVs) contribute to angiogenesis and vasculogenesis, but the mechanisms underlying these contributions have not been fully elucidated. In the present study, we investigated whether PMVs regulate the angiogenic properties of endothelial cells (ECs) via mechanisms extending beyond the transport of angiogenic regulators from platelets. METHODS: In vitro Matrigel tube formation assay and in vivo Matrigel plug assay were used to evaluate the pro-angiogenic activity of PMVs. The effects of PMVs on the migration of human umbilical vein endothelial cells (HUVECs) were detected by transwell assay and wound-healing assay. Real-time PCR and western blot were conducted to examine mRNA and protein expression of pro-angiogenic factors in HUVECs. Matrix metalloproteinase (MMP) activity was assayed by gelatin zymography. Moreover, the effects of specific MMP inhibitors were tested. RESULTS: PMVs promoted HUVEC capillary-like network formation in a dose-dependent manner. Meanwhile, PMVs dose-dependently facilitated HUVEC migration. Levels of MMP-2 and MMP-9 expression and activity were up-regulated in HUVECs stimulated with PMVs. Inhibition of MMPs decreased their pro-angiogenic and pro-migratory effects on HUVECs. Moreover, we confirmed the pro-angiogenic activity of PMVs in vivo in mice with subcutaneous implantation of Matrigel, and demonstrated that blockade of MMPs attenuated PMV-induced angiogenesis. CONCLUSION: The findings of our study indicate that PMVs promote angiogenesis by up-regulating MMP expression in ECs via mechanism extending beyond the direct delivery of angiogenic factors.
背景/目的:血小板微囊(PMV)有助于血管生成和血管发生,但其潜在机制尚未完全阐明。在本研究中,我们调查了PMV是否通过超出从血小板转运血管生成调节因子的机制来调节内皮细胞(EC)的血管生成特性。 方法:采用体外基质胶管形成试验和体内基质胶栓塞试验评估PMV的促血管生成活性。通过Transwell试验和伤口愈合试验检测PMV对人脐静脉内皮细胞(HUVEC)迁移的影响。进行实时PCR和蛋白质印迹以检测HUVEC中促血管生成因子的mRNA和蛋白质表达。通过明胶酶谱法测定基质金属蛋白酶(MMP)活性。此外,测试了特异性MMP抑制剂的作用。 结果:PMV以剂量依赖性方式促进HUVEC毛细血管样网络形成。同时,PMV剂量依赖性地促进HUVEC迁移。在用PMV刺激的HUVEC中,MMP-2和MMP-9的表达水平和活性上调。抑制MMP可降低其对HUVEC的促血管生成和促迁移作用。此外,我们在皮下植入基质胶的小鼠体内证实了PMV的促血管生成活性,并证明阻断MMP可减弱PMV诱导的血管生成。 结论:我们的研究结果表明,PMV通过上调EC中MMP的表达促进血管生成,其机制超出了血管生成因子的直接递送。
Chin Med J (Engl). 2006-4-5
Arch Dermatol Res. 2025-1-24
Circ Res. 2023-3-17